Dr. Wu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Pathology Associates Wrn 2
Boston, MA 02114Phone+1 617-726-2967Fax+1 617-726-7474
Summary
- Dr. Chin-Lee Wu is a pathologist in Boston, MA and is affiliated with multiple hospitals in the area, including Massachusetts General Hospital and Newton-Wellesley Hospital. He received his medical degree from Southern Medical University and has been in practice 34 years. He specializes in genitourinary pathology, molecular genetics, anatomic pathology, and clinical pathology and is experienced in genitourinary pathology. He has more than 200 publications and over 15000 citings.
Education & Training
- Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1995 - 1999
- Southern Medical UniversityClass of 1983
Certifications & Licensure
- MA State Medical License 1998 - 2025
- American Board of Pathology Anatomic Pathology
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 291 citationsInsulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway.Hui H. Zhang, Jingxiang Huang, Katrin Düvel, Bernard Boback, Shulin Wu
Plos One. 2009-07-10 - 51 citationsNCOA5 Haploinsufficiency Results in Glucose Intolerance and Subsequent Hepatocellular CarcinomaShenglan Gao, Aimin Li, Feiye Liu, Fengsheng Chen, Mark Williams
Cancer Cell. 2013-12-09 - 31 citationsDownregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.Liang Chen, Rui Cao, Gang Wang, Lushun Yuan, Guofeng Qian
Medical Oncology. 2017-06-01
Press Mentions
- Gene-Expression Signature May Signify Risk for Recurrence, Metastasis in Prostate CancerApril 15th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: